Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

26.41
+1.656.66%
Pre-market: 25.88-0.5300-2.01%04:40 EST
Volume:11.71M
Turnover:300.80M
Market Cap:10.32B
PE:-3.28
High:26.62
Open:24.95
Low:24.71
Close:24.76
52wk High:48.92
52wk Low:23.04
Shares:390.68M
Float Shares:363.29M
Volume Ratio:0.98
T/O Rate:3.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0516
EPS(LYR):-9.2734
ROE:-29.32%
ROA:-15.49%
PB:1.11
PE(LYR):-2.85

Loading ...

Stock Track | Moderna Soars 7.35% on Strong Q3 Results and Positive Outlook

Stock Track
·
12 hours ago

Moderna Inc. Stock Rallies 6.7%, Outperforms Peers

Dow Jones
·
12 hours ago

Moderna's Cost-Cutting, Pipeline Catalysts Set Stage for 2026 Upside, UBS Says

MT Newswires Live
·
13 hours ago

Rothschild & Co Redburn Adjusts Price Target on Moderna to $36 From $53, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

Moderna Is Maintained at Underperform by B of A Securities

Dow Jones
·
Nov 10

Moderna : Bofa Global Research Cuts Price Objective to $21 From $24

THOMSON REUTERS
·
Nov 10

Moderna price target lowered to $21 from $24 at BofA

TIPRANKS
·
Nov 10

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live
·
Nov 08

Leerink Partners Adjusts Moderna Price Target to $15 From $12

MT Newswires Live
·
Nov 08

Moderna Continues to Target Cash Breakeven in 2028, Morgan Stanley Says

MT Newswires Live
·
Nov 08

Morgan Stanley Trims Price Target on Moderna to $30 From $32, Keeps Equalweight Rating

MT Newswires Live
·
Nov 07

mRNA Vaccine Maker Moderna Lowers R&D Spending, Tightens Sales Forecast

Benzinga
·
Nov 07

Cautious Hold on Moderna: Awaiting Financial Stability Amid Revenue Shortfall and Promising Oncology Developments

TIPRANKS
·
Nov 07

Moderna Exec Says Co Is Looking for Deals to Fund Development of Its Ebv Vaccine - Conf Call

THOMSON REUTERS
·
Nov 06

Moderna Shares Extend Premarket Gains, Last up 9.6%

THOMSON REUTERS
·
Nov 06

Moderna trims annual expenses outlook on lower production costs, R&D cuts

Reuters
·
Nov 06

Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines

Trading Random
·
Nov 06

GUIDANCE: (MRNA) Moderna Expects 2025 Revenue Range $1.6B - $2.0B, vs. FactSet Est of $1.89B

MT Newswires Live
·
Nov 06

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

Dow Jones
·
Nov 06

Earnings Flash (MRNA) Moderna Posts Q3 Loss $0.51 a Share, vs. FactSet Est of $2 Loss

MT Newswires Live
·
Nov 06